

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.13223190 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.13223190 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.55357398 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.24345025 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.39557794 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.06777586 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88574134 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88574134 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.88574134 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88574134 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.88574134 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88574134 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 3.72310982 |
| 14 | response to peptidoglycan (GO:0032494) | 3.71366549 |
| 15 | detection of bacterium (GO:0016045) | 3.68979840 |
| 16 | detection of other organism (GO:0098543) | 3.66179900 |
| 17 | positive thymic T cell selection (GO:0045059) | 3.59232794 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58472300 |
| 19 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.56918438 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49687890 |
| 21 | germinal center formation (GO:0002467) | 3.46056145 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43068455 |
| 23 | positive regulation of histone deacetylation (GO:0031065) | 3.33453045 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.32368673 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.26205338 |
| 26 | leukocyte aggregation (GO:0070486) | 3.26044828 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.24515449 |
| 28 | regulation of B cell differentiation (GO:0045577) | 3.20965056 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.18242126 |
| 30 | negative T cell selection (GO:0043383) | 3.16349847 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14457641 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12810973 |
| 33 | negative regulation of phagocytosis (GO:0050765) | 3.12022906 |
| 34 | viral transcription (GO:0019083) | 3.10739362 |
| 35 | thymic T cell selection (GO:0045061) | 3.10200304 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09663740 |
| 37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07397221 |
| 38 | pentose-phosphate shunt (GO:0006098) | 3.02245626 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.01060319 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99719732 |
| 41 | translational termination (GO:0006415) | 2.91726500 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89227423 |
| 43 | negative regulation of cell killing (GO:0031342) | 2.89227423 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87131915 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85774616 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 2.85637294 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85520589 |
| 48 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81869694 |
| 49 | natural killer cell differentiation (GO:0001779) | 2.81207242 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 2.79208006 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 2.78363753 |
| 52 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.77497092 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.75878086 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75838921 |
| 55 | definitive hemopoiesis (GO:0060216) | 2.74447471 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 2.72566082 |
| 57 | mannose metabolic process (GO:0006013) | 2.71927590 |
| 58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71578778 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71413117 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70020553 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.67736822 |
| 62 | positive regulation of protein deacetylation (GO:0090312) | 2.66760612 |
| 63 | translational elongation (GO:0006414) | 2.64700233 |
| 64 | detection of biotic stimulus (GO:0009595) | 2.64229610 |
| 65 | valine metabolic process (GO:0006573) | 2.64189248 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63461531 |
| 67 | defense response to protozoan (GO:0042832) | 2.63212656 |
| 68 | T cell migration (GO:0072678) | 2.61973170 |
| 69 | megakaryocyte development (GO:0035855) | 2.60854068 |
| 70 | T cell apoptotic process (GO:0070231) | 2.60033636 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 2.60020404 |
| 72 | regulation of tolerance induction (GO:0002643) | 2.57477510 |
| 73 | T cell selection (GO:0045058) | 2.56844489 |
| 74 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.56440895 |
| 75 | modulation by symbiont of host cellular process (GO:0044068) | 2.56020338 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55462087 |
| 77 | response to host (GO:0075136) | 2.55462087 |
| 78 | response to host defenses (GO:0052200) | 2.55462087 |
| 79 | regulation of extracellular matrix disassembly (GO:0010715) | 2.54786261 |
| 80 | response to protozoan (GO:0001562) | 2.54626748 |
| 81 | NADPH regeneration (GO:0006740) | 2.54604066 |
| 82 | morphogenesis of an endothelium (GO:0003159) | 2.53757821 |
| 83 | endothelial tube morphogenesis (GO:0061154) | 2.53757821 |
| 84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53208467 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 2.53206393 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52910745 |
| 87 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.51178311 |
| 88 | response to host immune response (GO:0052572) | 2.50363059 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50363059 |
| 90 | regulation of natural killer cell differentiation (GO:0032823) | 2.49612660 |
| 91 | cellular extravasation (GO:0045123) | 2.49462652 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.49428532 |
| 93 | modulation by virus of host process (GO:0019054) | 2.46757597 |
| 94 | regulation of necroptotic process (GO:0060544) | 2.46485496 |
| 95 | response to muramyl dipeptide (GO:0032495) | 2.46382326 |
| 96 | negative regulation of interleukin-6 production (GO:0032715) | 2.45762229 |
| 97 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.45706658 |
| 98 | response to type I interferon (GO:0034340) | 2.45625130 |
| 99 | T cell homeostasis (GO:0043029) | 2.45285907 |
| 100 | negative regulation of granulocyte differentiation (GO:0030853) | 2.45092574 |
| 101 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.44602995 |
| 102 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.44602995 |
| 103 | regulation of erythrocyte differentiation (GO:0045646) | 2.44342481 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 2.44093724 |
| 105 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43966417 |
| 106 | DNA unwinding involved in DNA replication (GO:0006268) | 2.43480817 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43179510 |
| 108 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.42284301 |
| 109 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.42182406 |
| 110 | cellular response to zinc ion (GO:0071294) | 2.41233941 |
| 111 | pinocytosis (GO:0006907) | 2.40949946 |
| 112 | negative regulation of type 2 immune response (GO:0002829) | 2.40498373 |
| 113 | myeloid cell activation involved in immune response (GO:0002275) | 2.40380657 |
| 114 | regulation of antigen processing and presentation (GO:0002577) | 2.39462339 |
| 115 | cellular response to type I interferon (GO:0071357) | 2.38071753 |
| 116 | type I interferon signaling pathway (GO:0060337) | 2.38071753 |
| 117 | protein targeting to ER (GO:0045047) | 2.37551382 |
| 118 | positive T cell selection (GO:0043368) | 2.37486550 |
| 119 | regulation of response to interferon-gamma (GO:0060330) | 2.37069182 |
| 120 | leukocyte cell-cell adhesion (GO:0007159) | 2.36816711 |
| 121 | cotranslational protein targeting to membrane (GO:0006613) | 2.33134461 |
| 122 | lymphocyte homeostasis (GO:0002260) | 2.32697355 |
| 123 | negative regulation of stress fiber assembly (GO:0051497) | 2.31744196 |
| 124 | embryonic hemopoiesis (GO:0035162) | 2.30189243 |
| 125 | B cell mediated immunity (GO:0019724) | 2.29941952 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.29068873 |
| 127 | lymphocyte apoptotic process (GO:0070227) | 2.28602038 |
| 128 | viral life cycle (GO:0019058) | 2.28516144 |
| 129 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.26966351 |
| 130 | actin nucleation (GO:0045010) | 2.26503848 |
| 131 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.25515599 |
| 132 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.24938369 |
| 133 | negative regulation of innate immune response (GO:0045824) | 2.20773517 |
| 134 | response to interleukin-15 (GO:0070672) | 2.20495014 |
| 135 | interferon-gamma production (GO:0032609) | 2.19310355 |
| 136 | tolerance induction (GO:0002507) | 2.18605547 |
| 137 | protein localization to endoplasmic reticulum (GO:0070972) | 2.18514695 |
| 138 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.18435289 |
| 139 | immunoglobulin mediated immune response (GO:0016064) | 2.18237073 |
| 140 | maternal placenta development (GO:0001893) | 2.17281341 |
| 141 | positive regulation of lamellipodium assembly (GO:0010592) | 2.16760676 |
| 142 | negative regulation of RNA splicing (GO:0033119) | 2.16428426 |
| 143 | Golgi transport vesicle coating (GO:0048200) | 2.16211773 |
| 144 | COPI coating of Golgi vesicle (GO:0048205) | 2.16211773 |
| 145 | hepatocyte apoptotic process (GO:0097284) | 2.14030608 |
| 146 | adaptation of signaling pathway (GO:0023058) | 2.13548555 |
| 147 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.12856429 |
| 148 | Peyers patch development (GO:0048541) | 2.12856429 |
| 149 | positive regulation of isotype switching (GO:0045830) | 2.12461632 |
| 150 | leukocyte homeostasis (GO:0001776) | 2.12235913 |
| 151 | defense response to fungus (GO:0050832) | 2.10713834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13196554 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.30216416 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.19273657 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90482228 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.83134852 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.74102041 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.73826514 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.60501135 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56345062 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41996320 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.36974670 |
| 12 | * MAF_26560356_Chip-Seq_TH1_Human | 2.12133786 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.06419920 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.05361016 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04525388 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02972541 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01450662 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95565441 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95526145 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95082232 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90149243 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88194534 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85948211 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85801362 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85102125 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83862658 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.82404034 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82144185 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78815845 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.78053173 |
| 31 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76238149 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74596943 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73179629 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72657933 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71565442 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69499565 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67778185 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66832648 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66492847 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65589255 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64365602 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63137763 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62976791 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62671624 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60468686 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59638565 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55611009 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54031556 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53875965 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53381873 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50535692 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49733312 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48621217 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48051539 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47235795 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46643327 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45478980 |
| 58 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45374999 |
| 59 | * MAF_26560356_Chip-Seq_TH2_Human | 1.42923892 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42529836 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42246478 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41945330 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.41609658 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38499390 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36683007 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35828314 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34354942 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33642027 |
| 69 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32035625 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29221268 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26478970 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26399155 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26075585 |
| 74 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23005367 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22728017 |
| 76 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.22095598 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22076281 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21677827 |
| 79 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21208907 |
| 80 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20295015 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19912677 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19892242 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19169912 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18818038 |
| 85 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18691000 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17708926 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17020906 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15927030 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15207777 |
| 90 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13723512 |
| 91 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10470317 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10217301 |
| 93 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09028315 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08742031 |
| 95 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07770883 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06573084 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05009971 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04779071 |
| 99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03686899 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03651483 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03581681 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02294790 |
| 103 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01419414 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00241838 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99939694 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99912705 |
| 107 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99408229 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98564951 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98098344 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97875847 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97801239 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97196233 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96601405 |
| 114 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96069556 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95766985 |
| 116 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95624598 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94817139 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94142166 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.93860597 |
| 120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93791750 |
| 121 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93664901 |
| 122 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.91582171 |
| 123 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90727654 |
| 124 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90036629 |
| 125 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89129365 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88277762 |
| 127 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87784828 |
| 128 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86416913 |
| 129 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86322864 |
| 130 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85846930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 2.73553894 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.54927380 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.52334625 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.35809932 |
| 5 | MP0003436_decreased_susceptibility_to | 2.30937268 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.25524453 |
| 7 | MP0001800_abnormal_humoral_immune | 2.19902463 |
| 8 | MP0009278_abnormal_bone_marrow | 2.15361020 |
| 9 | MP0005387_immune_system_phenotype | 2.14151981 |
| 10 | MP0001790_abnormal_immune_system | 2.14151981 |
| 11 | MP0005451_abnormal_body_composition | 2.14014828 |
| 12 | MP0003303_peritoneal_inflammation | 2.08682154 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.04297572 |
| 14 | MP0008260_abnormal_autophagy | 1.95240610 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 1.94752547 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 1.93396903 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.92175360 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.90398601 |
| 19 | MP0002452_abnormal_antigen_presenting | 1.89362069 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.85572768 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.85572768 |
| 22 | MP0003011_delayed_dark_adaptation | 1.84029512 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.84011146 |
| 24 | MP0002398_abnormal_bone_marrow | 1.82739780 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.78963416 |
| 26 | MP0002723_abnormal_immune_serum | 1.77554768 |
| 27 | MP0001819_abnormal_immune_cell | 1.77420283 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.77330411 |
| 29 | MP0005025_abnormal_response_to | 1.74053024 |
| 30 | MP0001873_stomach_inflammation | 1.71385017 |
| 31 | MP0009840_abnormal_foam_cell | 1.70033962 |
| 32 | MP0004947_skin_inflammation | 1.69536516 |
| 33 | MP0005671_abnormal_response_to | 1.68591860 |
| 34 | MP0009785_altered_susceptibility_to | 1.65911993 |
| 35 | MP0002722_abnormal_immune_system | 1.61785294 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.61500185 |
| 37 | MP0002419_abnormal_innate_immunity | 1.61364851 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.59811033 |
| 39 | MP0000716_abnormal_immune_system | 1.58966761 |
| 40 | MP0002405_respiratory_system_inflammati | 1.56773271 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.54412761 |
| 42 | MP0003828_pulmonary_edema | 1.53688975 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.53107603 |
| 44 | MP0002429_abnormal_blood_cell | 1.45417236 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.41391107 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.38470915 |
| 47 | MP0004381_abnormal_hair_follicle | 1.37295759 |
| 48 | MP0005023_abnormal_wound_healing | 1.35606708 |
| 49 | MP0003091_abnormal_cell_migration | 1.35049122 |
| 50 | MP0003724_increased_susceptibility_to | 1.34395752 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.33022518 |
| 52 | MP0001853_heart_inflammation | 1.31875464 |
| 53 | MP0000490_abnormal_crypts_of | 1.27899606 |
| 54 | MP0006054_spinal_hemorrhage | 1.27004795 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.24547625 |
| 56 | MP0000858_altered_metastatic_potential | 1.23139857 |
| 57 | MP0002006_tumorigenesis | 1.22707947 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.20846211 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.18454841 |
| 60 | MP0002933_joint_inflammation | 1.18317559 |
| 61 | MP0003866_abnormal_defecation | 1.15514497 |
| 62 | MP0003279_aneurysm | 1.14414937 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.13663844 |
| 64 | MP0010307_abnormal_tumor_latency | 1.09679056 |
| 65 | MP0002148_abnormal_hypersensitivity_rea | 1.09008324 |
| 66 | MP0003075_altered_response_to | 1.08048006 |
| 67 | MP0006082_CNS_inflammation | 1.07872019 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.07867848 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.06268660 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.05132866 |
| 71 | MP0005310_abnormal_salivary_gland | 1.04486632 |
| 72 | MP0008469_abnormal_protein_level | 1.02440321 |
| 73 | MP0005390_skeleton_phenotype | 1.01887777 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.00862825 |
| 75 | MP0002019_abnormal_tumor_incidence | 0.99903498 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.98845043 |
| 77 | MP0002060_abnormal_skin_morphology | 0.97818533 |
| 78 | MP0000609_abnormal_liver_physiology | 0.97807875 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.94270817 |
| 80 | MP0004858_abnormal_nervous_system | 0.93880919 |
| 81 | MP0003690_abnormal_glial_cell | 0.91889317 |
| 82 | MP0004510_myositis | 0.90921586 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.89056129 |
| 84 | MP0000604_amyloidosis | 0.88610036 |
| 85 | MP0001851_eye_inflammation | 0.87912935 |
| 86 | MP0001915_intracranial_hemorrhage | 0.87549892 |
| 87 | MP0003448_altered_tumor_morphology | 0.87347018 |
| 88 | MP0000249_abnormal_blood_vessel | 0.86687976 |
| 89 | MP0000598_abnormal_liver_morphology | 0.86612738 |
| 90 | MP0005166_decreased_susceptibility_to | 0.86185139 |
| 91 | MP0000343_altered_response_to | 0.86115223 |
| 92 | MP0005409_darkened_coat_color | 0.84306433 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.82494077 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.82464331 |
| 95 | MP0005365_abnormal_bile_salt | 0.80782386 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.80752112 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.80305498 |
| 98 | MP0001663_abnormal_digestive_system | 0.79849698 |
| 99 | MP0001958_emphysema | 0.79727885 |
| 100 | MP0004883_abnormal_blood_vessel | 0.79373917 |
| 101 | MP0003077_abnormal_cell_cycle | 0.79336906 |
| 102 | MP0003795_abnormal_bone_structure | 0.78775527 |
| 103 | MP0008007_abnormal_cellular_replicative | 0.78542884 |
| 104 | MP0002796_impaired_skin_barrier | 0.77564140 |
| 105 | MP0005164_abnormal_response_to | 0.77196721 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.76429482 |
| 107 | MP0009763_increased_sensitivity_to | 0.76074157 |
| 108 | MP0001243_abnormal_dermal_layer | 0.75675044 |
| 109 | MP0005360_urolithiasis | 0.75332343 |
| 110 | MP0009764_decreased_sensitivity_to | 0.74936447 |
| 111 | MP0004130_abnormal_muscle_cell | 0.74601170 |
| 112 | MP0000678_abnormal_parathyroid_gland | 0.73473806 |
| 113 | MP0002009_preneoplasia | 0.72798151 |
| 114 | MP0009931_abnormal_skin_appearance | 0.72671263 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.72667930 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.72119662 |
| 117 | MP0003045_fibrosis | 0.71560287 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.70814374 |
| 119 | MP0003252_abnormal_bile_duct | 0.70664929 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.70506711 |
| 121 | MP0001849_ear_inflammation | 0.70457693 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.70277499 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.70180712 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.70065052 |
| 125 | MP0009115_abnormal_fat_cell | 0.68683563 |
| 126 | MP0002132_abnormal_respiratory_system | 0.68535841 |
| 127 | MP0000477_abnormal_intestine_morphology | 0.68388454 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.67026728 |
| 129 | MP0003111_abnormal_nucleus_morphology | 0.66932750 |
| 130 | MP0000350_abnormal_cell_proliferation | 0.66887348 |
| 131 | MP0003943_abnormal_hepatobiliary_system | 0.66581421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 3.50463254 |
| 2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.25905690 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.22930330 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20788964 |
| 5 | Chronic otitis media (HP:0000389) | 3.19141943 |
| 6 | Thrombocytosis (HP:0001894) | 3.14882672 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14719972 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 3.13993934 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.08036088 |
| 10 | IgM deficiency (HP:0002850) | 2.97679006 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 2.94628921 |
| 12 | Recurrent viral infections (HP:0004429) | 2.91939558 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 2.91177210 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 2.88704799 |
| 15 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.86631292 |
| 16 | Myositis (HP:0100614) | 2.83674603 |
| 17 | Inflammation of the large intestine (HP:0002037) | 2.83335249 |
| 18 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.82530952 |
| 19 | Nasal polyposis (HP:0100582) | 2.80676317 |
| 20 | Pigmentary retinal degeneration (HP:0001146) | 2.77593999 |
| 21 | Cellulitis (HP:0100658) | 2.75989091 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75249118 |
| 23 | Obstructive lung disease (HP:0006536) | 2.75249118 |
| 24 | Colitis (HP:0002583) | 2.73962014 |
| 25 | Recurrent fungal infections (HP:0002841) | 2.69252600 |
| 26 | Abnormality of the fingertips (HP:0001211) | 2.66044784 |
| 27 | Gingivitis (HP:0000230) | 2.63943848 |
| 28 | Obstructive sleep apnea (HP:0002870) | 2.63323609 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 2.61867276 |
| 30 | Pustule (HP:0200039) | 2.61825685 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.61625260 |
| 32 | Recurrent abscess formation (HP:0002722) | 2.61147559 |
| 33 | Abnormal platelet function (HP:0011869) | 2.59609609 |
| 34 | Impaired platelet aggregation (HP:0003540) | 2.59609609 |
| 35 | Cerebral aneurysm (HP:0004944) | 2.53993214 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.52965711 |
| 37 | Petechiae (HP:0000967) | 2.46903471 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 2.42473489 |
| 39 | T lymphocytopenia (HP:0005403) | 2.40840859 |
| 40 | Broad face (HP:0000283) | 2.40707219 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.39555425 |
| 42 | Abnormality of T cells (HP:0002843) | 2.39348112 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.38632837 |
| 44 | Gastrointestinal stroma tumor (HP:0100723) | 2.38479575 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.37912440 |
| 46 | Optic neuritis (HP:0100653) | 2.37912440 |
| 47 | Periodontitis (HP:0000704) | 2.37329023 |
| 48 | Epistaxis (HP:0000421) | 2.35958007 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33792184 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33792184 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33792184 |
| 52 | Hematochezia (HP:0002573) | 2.33209191 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.33105359 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.32489548 |
| 55 | Stomatitis (HP:0010280) | 2.30804332 |
| 56 | Abnormal platelet volume (HP:0011876) | 2.27594051 |
| 57 | Increased IgE level (HP:0003212) | 2.25693935 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25321368 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25321368 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25321368 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.24715760 |
| 62 | Increased density of long bones (HP:0006392) | 2.22640790 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.18024847 |
| 64 | Granulocytopenia (HP:0001913) | 2.17880175 |
| 65 | Gingival bleeding (HP:0000225) | 2.16211281 |
| 66 | Aortic aneurysm (HP:0004942) | 2.15721747 |
| 67 | Pendular nystagmus (HP:0012043) | 2.14428621 |
| 68 | Meningitis (HP:0001287) | 2.14166567 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.12445048 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.11892239 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11213038 |
| 72 | Polygenic inheritance (HP:0010982) | 2.10713071 |
| 73 | Posterior subcapsular cataract (HP:0007787) | 2.08567828 |
| 74 | Lymphopenia (HP:0001888) | 2.08304749 |
| 75 | Emphysema (HP:0002097) | 2.07866866 |
| 76 | Loss of speech (HP:0002371) | 2.05574224 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03916691 |
| 78 | Hyperacusis (HP:0010780) | 2.03657625 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.03301812 |
| 80 | Hypertriglyceridemia (HP:0002155) | 2.02796922 |
| 81 | Dilatation of the ascending aorta (HP:0005111) | 2.02015393 |
| 82 | Agammaglobulinemia (HP:0004432) | 2.00475913 |
| 83 | Verrucae (HP:0200043) | 2.00381707 |
| 84 | Papilloma (HP:0012740) | 2.00381707 |
| 85 | Increased connective tissue (HP:0009025) | 1.98094375 |
| 86 | Amyloidosis (HP:0011034) | 1.97927348 |
| 87 | Purpura (HP:0000979) | 1.97598673 |
| 88 | Increased mean platelet volume (HP:0011877) | 1.96575826 |
| 89 | Hemoptysis (HP:0002105) | 1.95993605 |
| 90 | Encephalitis (HP:0002383) | 1.95970499 |
| 91 | Slow saccadic eye movements (HP:0000514) | 1.95710027 |
| 92 | Vasculitis (HP:0002633) | 1.94922053 |
| 93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94416676 |
| 94 | Osteomyelitis (HP:0002754) | 1.94342365 |
| 95 | Joint stiffness (HP:0001387) | 1.93950642 |
| 96 | Recurrent skin infections (HP:0001581) | 1.92685406 |
| 97 | Arterial thrombosis (HP:0004420) | 1.90596325 |
| 98 | Restrictive lung disease (HP:0002091) | 1.89538979 |
| 99 | Poikiloderma (HP:0001029) | 1.89489444 |
| 100 | Increased serum ferritin (HP:0003281) | 1.88313830 |
| 101 | Peritonitis (HP:0002586) | 1.86951623 |
| 102 | Ulnar bowing (HP:0003031) | 1.86685356 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 1.85278768 |
| 104 | Chest pain (HP:0100749) | 1.85254429 |
| 105 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84522123 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 1.84443819 |
| 107 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83534344 |
| 108 | Hypertensive crisis (HP:0100735) | 1.83176201 |
| 109 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82688620 |
| 110 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82688620 |
| 111 | Mediastinal lymphadenopathy (HP:0100721) | 1.81962812 |
| 112 | Polycythemia (HP:0001901) | 1.81742226 |
| 113 | Hepatosplenomegaly (HP:0001433) | 1.81713134 |
| 114 | Aneurysm (HP:0002617) | 1.81511010 |
| 115 | Myocardial infarction (HP:0001658) | 1.81174469 |
| 116 | Spondylolisthesis (HP:0003302) | 1.80323276 |
| 117 | Orchitis (HP:0100796) | 1.80082720 |
| 118 | Easy fatigability (HP:0003388) | 1.78984436 |
| 119 | Abnormality of the thoracic spine (HP:0100711) | 1.78789611 |
| 120 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78010691 |
| 121 | Chorioretinal atrophy (HP:0000533) | 1.76848393 |
| 122 | Skin ulcer (HP:0200042) | 1.76831607 |
| 123 | Thoracic kyphosis (HP:0002942) | 1.76480139 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75865414 |
| 125 | Abnormality of macrophages (HP:0004311) | 1.75818675 |
| 126 | Premature loss of primary teeth (HP:0006323) | 1.75711536 |
| 127 | Entropion (HP:0000621) | 1.74730736 |
| 128 | Dysostosis multiplex (HP:0000943) | 1.74317922 |
| 129 | Urticaria (HP:0001025) | 1.74154559 |
| 130 | Disproportionate tall stature (HP:0001519) | 1.73980708 |
| 131 | Abnormal number of erythroid precursors (HP:0012131) | 1.73717118 |
| 132 | Mucopolysacchariduria (HP:0008155) | 1.73386781 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73386781 |
| 134 | Cervical subluxation (HP:0003308) | 1.73327468 |
| 135 | Vacuolated lymphocytes (HP:0001922) | 1.71348021 |
| 136 | Microcytic anemia (HP:0001935) | 1.71233339 |
| 137 | Increased cerebral lipofuscin (HP:0011813) | 1.71068448 |
| 138 | High pitched voice (HP:0001620) | 1.70658404 |
| 139 | Basal cell carcinoma (HP:0002671) | 1.69134741 |
| 140 | Radial bowing (HP:0002986) | 1.65966587 |
| 141 | Ankle contracture (HP:0006466) | 1.65687664 |
| 142 | Reticulocytopenia (HP:0001896) | 1.65660083 |
| 143 | Fatigue (HP:0012378) | 1.65568120 |
| 144 | Scotoma (HP:0000575) | 1.65385672 |
| 145 | Thin bony cortex (HP:0002753) | 1.64595448 |
| 146 | Menorrhagia (HP:0000132) | 1.63924194 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.63749869 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63749869 |
| 149 | Hypochromic anemia (HP:0001931) | 1.63580227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.92429971 |
| 2 | PRPF4B | 3.47103470 |
| 3 | ERN1 | 3.34682700 |
| 4 | TRIB3 | 3.21206424 |
| 5 | MAP3K10 | 3.08932085 |
| 6 | RIPK4 | 2.78131580 |
| 7 | PKN2 | 2.74717159 |
| 8 | EEF2K | 2.66668815 |
| 9 | JAK3 | 2.18925506 |
| 10 | SMG1 | 2.16968092 |
| 11 | STK10 | 2.15646678 |
| 12 | TYK2 | 2.07875821 |
| 13 | MAP2K3 | 2.01184276 |
| 14 | ZAP70 | 1.88799549 |
| 15 | BTK | 1.85141853 |
| 16 | LRRK2 | 1.81526149 |
| 17 | FGFR4 | 1.72129790 |
| 18 | SIK1 | 1.68196875 |
| 19 | FLT3 | 1.67737291 |
| 20 | KIT | 1.65002028 |
| 21 | RPS6KA4 | 1.61551691 |
| 22 | TNK2 | 1.58706736 |
| 23 | TGFBR2 | 1.56317066 |
| 24 | CDK12 | 1.55485026 |
| 25 | TBK1 | 1.55422872 |
| 26 | PTK6 | 1.54458627 |
| 27 | GRK6 | 1.46952734 |
| 28 | BLK | 1.46742922 |
| 29 | ICK | 1.46576278 |
| 30 | TTN | 1.45327162 |
| 31 | CSF1R | 1.39788985 |
| 32 | TAOK3 | 1.39209496 |
| 33 | ITK | 1.37425371 |
| 34 | NME2 | 1.37165076 |
| 35 | KDR | 1.36910215 |
| 36 | NEK2 | 1.34894784 |
| 37 | CDC42BPA | 1.30500863 |
| 38 | JAK1 | 1.25572143 |
| 39 | MARK2 | 1.23243707 |
| 40 | SIK3 | 1.22821966 |
| 41 | TEC | 1.19023888 |
| 42 | CSK | 1.16519850 |
| 43 | EPHB1 | 1.14473508 |
| 44 | PASK | 1.12986398 |
| 45 | TGFBR1 | 1.12769471 |
| 46 | MAP3K1 | 1.12167440 |
| 47 | TXK | 1.10778821 |
| 48 | RIPK1 | 1.09661422 |
| 49 | MARK3 | 1.09125601 |
| 50 | TAOK2 | 1.07605939 |
| 51 | CDK4 | 1.01588660 |
| 52 | RPS6KB2 | 1.00268527 |
| 53 | IKBKE | 1.00070097 |
| 54 | PIM1 | 1.00044517 |
| 55 | SYK | 0.99052690 |
| 56 | MAP3K6 | 0.98142194 |
| 57 | MAP3K14 | 0.96757274 |
| 58 | SCYL2 | 0.94891986 |
| 59 | HCK | 0.91752880 |
| 60 | FGFR3 | 0.90662976 |
| 61 | MAPK12 | 0.89082439 |
| 62 | LCK | 0.87669726 |
| 63 | CDK6 | 0.86676356 |
| 64 | PDPK1 | 0.86205212 |
| 65 | SIK2 | 0.85107627 |
| 66 | HIPK2 | 0.84925445 |
| 67 | KSR2 | 0.84758622 |
| 68 | GRK1 | 0.84749373 |
| 69 | MAPK7 | 0.83389845 |
| 70 | MAP3K8 | 0.83077223 |
| 71 | IKBKB | 0.82508451 |
| 72 | PAK4 | 0.82099311 |
| 73 | MAP3K3 | 0.82051569 |
| 74 | JAK2 | 0.81659808 |
| 75 | CHUK | 0.81057871 |
| 76 | NEK9 | 0.79839903 |
| 77 | BCKDK | 0.77032478 |
| 78 | PDK1 | 0.74382237 |
| 79 | CAMKK1 | 0.74214587 |
| 80 | RPS6KL1 | 0.74074200 |
| 81 | RPS6KC1 | 0.74074200 |
| 82 | DYRK1B | 0.74074196 |
| 83 | IRAK2 | 0.70172056 |
| 84 | MAP3K7 | 0.70027189 |
| 85 | CAMK1D | 0.68713091 |
| 86 | RPS6KA2 | 0.67627102 |
| 87 | FGR | 0.65867689 |
| 88 | IRAK4 | 0.63651336 |
| 89 | MAP3K11 | 0.63605453 |
| 90 | NLK | 0.63579429 |
| 91 | MAP2K2 | 0.62559879 |
| 92 | MAP3K13 | 0.61713373 |
| 93 | PDGFRA | 0.60922879 |
| 94 | CDC7 | 0.60862425 |
| 95 | BRD4 | 0.59887321 |
| 96 | LYN | 0.59015850 |
| 97 | RET | 0.56020476 |
| 98 | PTK2 | 0.55794650 |
| 99 | MAPK11 | 0.55008331 |
| 100 | MTOR | 0.54727058 |
| 101 | FES | 0.54501353 |
| 102 | CDK9 | 0.53617227 |
| 103 | PAK2 | 0.52596865 |
| 104 | PRKD2 | 0.52386360 |
| 105 | ALK | 0.52087530 |
| 106 | IRAK1 | 0.51891841 |
| 107 | TESK1 | 0.51468881 |
| 108 | STK4 | 0.50469332 |
| 109 | TYRO3 | 0.50148894 |
| 110 | PRKCH | 0.49549559 |
| 111 | TIE1 | 0.49107134 |
| 112 | CLK1 | 0.48381360 |
| 113 | CDK7 | 0.48151333 |
| 114 | RPS6KA6 | 0.48042959 |
| 115 | BMX | 0.47693956 |
| 116 | IRAK3 | 0.47336792 |
| 117 | TRPM7 | 0.47112617 |
| 118 | MAPK4 | 0.45981485 |
| 119 | MAPKAPK2 | 0.45826745 |
| 120 | MAP2K6 | 0.45050448 |
| 121 | ACVR1B | 0.43918469 |
| 122 | TESK2 | 0.43769833 |
| 123 | MAPKAPK3 | 0.43337724 |
| 124 | TAOK1 | 0.42202940 |
| 125 | PRKG2 | 0.41862686 |
| 126 | PDGFRB | 0.40000697 |
| 127 | EPHA3 | 0.39280466 |
| 128 | STK38 | 0.39048192 |
| 129 | PIM2 | 0.38775350 |
| 130 | FYN | 0.38527385 |
| 131 | MATK | 0.38034675 |
| 132 | PRKD1 | 0.35386582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.64361940 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18090142 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09533330 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07866768 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 1.89264447 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85644030 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 1.84408909 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75997810 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.74459283 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.71460573 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71301501 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65025268 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60252724 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59004230 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55130337 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51714685 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47107382 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.45768241 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44874685 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43465055 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.42891011 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39518051 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38621163 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38405833 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36235465 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.34137071 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33279389 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.32071175 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30511468 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.30442288 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28430020 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26319855 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24240186 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23796719 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.22324145 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.19667806 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18406611 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.15694616 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.14195894 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12696051 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.10498176 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.09750577 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09211875 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07478947 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06628871 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06454418 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06276275 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03235940 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02694120 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02052470 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99604692 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99599590 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99583540 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99179887 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98774074 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96740760 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.96257268 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95834788 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.95460624 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94662325 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.94228592 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93814070 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92244957 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90326017 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89830983 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87896915 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86929454 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.86922891 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.85667485 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85325659 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84610866 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83701079 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83583518 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 0.82767354 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82482802 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81713972 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.81581368 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81511848 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79663525 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78124891 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76275404 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76182328 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.76069852 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76052836 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.75764817 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75754801 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74471435 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.74333883 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.73187468 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71753219 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71568431 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71206456 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.70364667 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.68673261 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.68180013 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68058456 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67881798 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66641437 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.66112486 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66023256 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65702820 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65639063 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65615426 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65007357 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64227421 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64133834 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62913934 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62698548 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.60569684 |
| 110 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60140846 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59936073 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.59617958 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58852068 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58760268 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58570372 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58279445 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57343018 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57183548 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.56728158 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56316710 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56253489 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55255287 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53491407 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52905107 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52002558 |
| 126 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51968957 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50675991 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.49367488 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48250145 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48000288 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47017800 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46241939 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45019855 |

